McKesson

YTD

ALL

Trade McKesson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MCK

McKesson Corp. engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions.

CEO

Brian Scott Tyler

CEOBrian Scott Tyler

Employees

43,000

Employees43,000

Headquarters

Irving, Texas

HeadquartersIrving, Texas

Founded

1833

Founded1833

Employees

43,000

Employees43,000

MCK Key Statistics

Market cap

88.43B

Market cap88.43B

Price-Earnings ratio

19.35

Price-Earnings ratio19.35

Dividend yield

0.43%

Dividend yield0.43%

Average volume

1.58M

Average volume1.58M

High today

$745.00

High today$745.00

Low today

$730.66

Low today$730.66

Open price

$735.58

Open price$735.58

Volume

863.90K

Volume863.90K

52 Week high

$999.00

52 Week high$999.00

52 Week low

$637.00

52 Week low$637.00

Stock Snapshot

The current McKesson(MCK) stock price is $734.82, with a market capitalization of 88.43B. The stock trades at a price-to-earnings (P/E) ratio of 19.35 and offers a dividend yield of 42.7%.

As of 2026-06-01, McKesson(MCK) stock has fluctuated between $730.66 and $745.00. The current price stands at $734.82, placing the stock +0.6% above today's low and -1.4% off the high.

The McKesson(MCK)'s current trading volume is 863.9K, compared to an average daily volume of 1.58M.

During the past year, McKesson(MCK) stock moved between $637.00 at its lowest and $999.00 at its peak.

MCK News

Simply Wall St 2d

McKesson’s ASCO 2026 Data Highlights Evolving Role In Community Oncology

McKesson (NYSE:MCK) supported new research presented at ASCO 2026 by The US Oncology Network. The study found that advanced practice provider led consult model...

MarketWatch 3d

McKesson Corp. stock underperforms Friday when compared to competitors - MarketWatch

...

Simply Wall St 3d

McKesson Expands Gene Therapy Role With Nanoscope InspiroGene Partnership

McKesson (NYSE:MCK) has been selected by Nanoscope Therapeutics to provide U.S. commercialization and supply chain support for a retinal gene therapy through it...

Analyst ratings

90%

of 21 ratings

Buy

90.5%

Hold

9.5%

Sell

More MCK News

Simply Wall St 5d

Assessing McKesson Valuation After Recent Share Price Weakness And Cooling Long Term Momentum

McKesson (MCK) stock has drawn fresh attention after recent trading, with the share price around $754.40 and returns down over the past month and past 3 months....

People also own

Based on the portfolios of people who own MCK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.